Trademark Attorney / Law Firm

James Hollin – Trademark Portfolio

James Hollin specializes in Class 44 (Medical Services) trademark filings before the United States Patent and Trademark Office (USPTO), with 2 of 4 total filings concentrated in this category. The practice also covers Class 25 (Clothing) along with 3 other Nice Classification classes. Filing activity spans from 2016 to 2026. Currently, 0 trademarks are registered and 3 are pending.

4 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

James Hollin's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

25
Clothing (1 filing)

Clothing, footwear, headgear

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademark applications has James Hollin filed?

James Hollin has filed 4 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 3 pending, 1 cancelled.

What trademark classes does James Hollin specialize in?

James Hollin has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 44 (Medical Services), Class 25 (Clothing), Class 30 (Staple Foods). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

How long has James Hollin been filing trademarks?

James Hollin's trademark filing history with the USPTO spans from 2016 to 2026, covering 10 years of trademark practice. During this period, James Hollin has handled 4 trademark applications.

What is James Hollin's trademark registration success rate?

James Hollin has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 3 applications are pending review.